reinnervate Ltd. is commercializing Alvetex, a three-dimensional scaffold for cell culture. By supporting cell cultures that are more representative of the original tissues, Alvetex cultures could help drug companies fail drugs at an earlier stage, and could reduce the numbers of animals required in testing, thereby saving money in drug development.
Phone: +44 (0)191 3343988
Web Site: www.reinnervate.com
Join thousands of industry professionals who rely on Scrip for daily insights
Already a subscriber?
Recent moves in the industry include C-suite changes at Essential Pharma, plus Kyverna Therapeutics gets new chief financial officer from Alector.
The Swiss company believes its platform can make radiopharmaceuticals easier to produce and more accessible to patients.
Lupin's choice of a Cimzia biosimilar candidate and partnering with Zentiva reflect a strategy to sort the wheat from the chaff. Of 118 biologics to lose patent protection between 2025 and 2034 as per IQVIA, it’s going for a biosimilar with a single competitor though there could be other spoilers
